絞り込み

17884

広告

マスク着用が顔認識システムに与える影響とは? ()

3つの要点 ?? コロナウイルスの流行を背景に、非接触型の本人確認としてマスクのまま顔認証できるとするサービスが増加 ?? しかし、マスク着用による顔認証システ...

  1. [企業] Scipher社の炎症性腸疾患...
  2. 子どもの姿勢観察を コロナで学校の健診困...
  3. [企業] TG社のリンパ腫薬umbral...
  4. 検証プラス・新型コロナ:聖路加国際病院の...

ニュース一覧

Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.

著者 Griffiths B , Ducharme FM
Cochrane Database Syst Rev.2013 Aug 21 ; 8():CD000060.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Evelina Chidlren's Hospital, St Thomas? Hospital, Westminster Bridge Road, London, UK, SE1 7EH.

スターを付ける スターを付ける     (11view , 0users)

Full Text Sources

Medical

Miscellaneous

Other Literature Sources

Research Materials

There are several treatment options for managing acute asthma exacerbations (sustained worsening of symptoms that do not subside with regular treatment and require a change in management). Guidelines advocate the use of inhaled short acting beta2-agonists (SABAs) in children experiencing an asthma exacerbation. Anticholinergic agents, such as ipratropium bromide and atropine sulfate, have a slower onset of action and weaker bronchodilating effect, but may specifically relieve cholinergic bronchomotor tone and decrease mucosal edema and secretions. Therefore, the combination of inhaled anticholinergics with SABAs may yield enhanced and prolonged bronchodilation.
PMID: 23966133 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード